Monoclonal Antibodies in Cancer Therapy

Jessica L Teeling, Ruth R French, Mark S Cragg, Jeroen van den Brakel, Marielle Pluyter, Haichun Huang, Claude Chan, Paul WHI Parren, C Erik Hack, Michael Dechant, Thomas Valerius, Jan GJ van de Winkel, Martin J Glennie, Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas Blood. ,vol. 104, pp. 1793- 1800 ,(2004) , 10.1182/BLOOD-2004-01-0039

D. Slamon, G. Clark, S. Wong, W. Levin, A Ullrich, W. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science. ,vol. 235, pp. 177- 182 ,(1987) , 10.1126/SCIENCE.3798106

Christoph Rader, Carlos F Barbas, Phage display of combinatorial antibody libraries. Current Opinion in Biotechnology. ,vol. 8, pp. 503- 508 ,(1997) , 10.1016/S0958-1669(97)80075-4

Laurence Besnault, Nicolas Schrantz, Marie Thérèse Auffredou, Gérald Leca, Marie Françoise Bourgeade, Aimé Vazquez, B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein. Journal of Immunology. ,vol. 167, pp. 733- 740 ,(2001) , 10.4049/JIMMUNOL.167.2.733

David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, Danny Bets, Matthias Mueser, Andreas Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem, None, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New England Journal of Medicine. ,vol. 351, pp. 337- 345 ,(2004) , 10.1056/NEJMOA033025

Michael J. Keating, Ian Flinn, Vinay Jain, Jacques-Louis Binet, Peter Hillmen, John Byrd, Maher Albitar, Lee Brettman, Pedro Santabarbara, Bret Wacker, Kanti R. Rai, Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood. ,vol. 99, pp. 3554- 3561 ,(2002) , 10.1182/BLOOD.V99.10.3554

Achim Knappik, Liming Ge, Annemarie Honegger, Peter Pack, Melanie Fischer, Günter Wellnhofer, Adolf Hoess, Joachim Wölle, Andreas Plückthun, Bernhard Virnekäs, Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. Journal of Molecular Biology. ,vol. 296, pp. 57- 86 ,(2000) , 10.1006/JMBI.1999.3444

Francisco J. Esteva, Vicente Valero, Daniel Booser, Laura T. Guerra, James L. Murray, Lajos Pusztai, Massimo Cristofanilli, Banu Arun, Bita Esmaeli, Herbert A. Fritsche, Nour Sneige, Terry L. Smith, Gabriel N. Hortobagyi, Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 20, pp. 1800- 1808 ,(2002) , 10.1200/JCO.2002.07.058

Myron S Czuczman, A Koryzna, A Mohr, C Stewart, K Donohue, L Blumenson, ZP Bernstein, P McCarthy, A Alam, F Hernandez-Ilizaliturri, M Skipper, K Brown, A Chanan-Khan, D Klippenstein, P Loud, MK Rock, M Benyunes, A Grillo-Lopez, SH Bernstein, None, Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma Journal of Clinical Oncology. ,vol. 23, pp. 694- 704 ,(2005) , 10.1200/JCO.2005.02.172

Thomas E. Witzig, Christine A. White, Leo I. Gordon, Gregory A. Wiseman, Christos Emmanouilides, James L. Murray, John Lister, Pratik S. Multani, Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma. Journal of Clinical Oncology. ,vol. 21, pp. 1263- 1270 ,(2003) , 10.1200/JCO.2003.08.043